文献速递乳腺癌放疗放疗物理与技术

乳腺癌调强放疗中两种剂量外扩方法的剂量学比较

Dosimetric comparison of two dose expansion methods in intensity modulated radiotherapy for breast cancer.
PubMed 文献 · Radiat Oncol · 2023-02-04

随机选取20例乳腺癌患者,分别设计基于虚拟bolus的IMRT-VB计划和基于Eclipse皮肤闪射工具的IMRT-SF计划,比较靶区与危及器官剂量参数。IMRT-SF计划的适形指数、均匀指数及D2%、D98%、D50%均显著优于IMRT-VB计划,平均机器跳数更高,同侧肺和脊髓保护更具优势。

要点

  • 两种计划均能外扩至胸壁皮肤并满足临床处方剂量要求。
  • IMRT-SF计划适形指数、均匀指数及D2%、D98%、D50%显著优于IMRT-VB计划(P<0.05)。
  • IMRT-SF计划平均机器跳数高于IMRT-VB计划(866.0±68.1 MU vs. 760.9±50.4 MU,P<0.05)。

核心结论

  • 作者认为IMRT-SF计划较IMRT-VB计划显示出临床应用优势,操作步骤更简单快捷,并在皮肤剂量强度有效外扩和危及器官保护方面具有优势。

研究设计与样本

  • 随机选取20例乳腺癌患者作为研究对象,分别设计基于虚拟bolus的IMRT-VB计划和基于Eclipse治疗计划系统皮肤闪射工具的IMRT-SF计划。
  • 记录计划靶区体积、每次治疗机器跳数及危及器官剂量学参数,正态分布数据采用配对t检验,非正态分布数据采用非参数配对Wilcoxon秩和检验。

主要发现

  • IMRT-VB和IMRT-SF计划均能向外扩展至胸壁皮肤并满足临床处方剂量要求。
  • IMRT-SF计划的适形指数、均匀指数、D2%、D98%和D50%均显著优于IMRT-VB计划(P<0.05)。
  • IMRT-SF计划平均机器跳数显著高于IMRT-VB计划(866.0±68.1 MU vs. 760.9±50.4 MU,P<0.05)。
  • 在危及器官保护方面,IMRT-SF计划对同侧肺和脊髓的保护较IMRT-VB计划更具优势(P<0.05)。

临床怎么用

  • 作者认为IMRT-SF计划较IMRT-VB计划具有临床应用优势,操作步骤更简单快捷,并在皮肤剂量强度有效外扩和危及器官保护方面具有优势。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To explore the dosimetric difference between IMRT-VB plan based on the establishment of external expansion structure and virtual bolus (VB) and IMRT-SF based on the skin flash (SF) tool of the Eclipse treatment planning system in postoperative chest wall target intensity modulation radiotherapy plan of breast cancer. METHODS: Twenty patients with breast cancer were randomly selected as subjects to develop IMRT-VB plan based on virtual bolus and IMRT-SF plan based on skin flash tool of Eclipse treatment planning system. The planning target volume, monitor unit (MU) of every single treatment and the dosimetric parameters of organ at risk (OARs) were recorded. Paired t-test was used for normal distribution data while nonparametric paired Wilcoxon rank sum test was used for non-normal distribution data. RESULTS: Both IMRT-VB and IMRT-SF plan can expand outward to the chest wall skin and meet the dose requirements of clinical prescription. The conformal index, the homogeneity index, D2%, D98% and D50% were significantly better in IMRT-SF plan than those in IMRT-VB plan (P < 0.05). The average MU of the IMRT-SF plan was much higher than that of the IMRT-VB plan (866.0 ± 68.1 MU vs. 760.9 ± 50.4 MU, P < 0.05). In terms of organ at risk protection, IMRT-SF plan had more advantages in the protection of ipsilateral lung and spinal cord than IMRT-VB plan (P < 0.05). CONCLUSION: Our study indicated that IMRT-SF plan displayed clinical application superiority compared to IMRT-VB plan, and the operation steps of which are simpler and faster. Besides, IMRT-SF plan took advantages in achieve effective external expansion of skin dose intensity and OARs protection.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Tang R, Li A, Li Y, et al. Dosimetric comparison of two dose expansion methods in intensity modulated radiotherapy for breast cancer. Radiat Oncol. 2023. PMID: 36737788. doi:10.1186/s13014-023-02217-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。